Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2006-03-09
2011-10-11
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
Reexamination Certificate
active
08034381
ABSTRACT:
The invention concerns a method for producing ultrafine suspensions, characterized in that a substance in the form of a solid product at 20° C. is dissolved in a solvent, in that the solvent is very rapidly substantially drawn from said solution, in that the powder thus obtained, whereof the particles have an average particle-size distribution of the order of 1 to 50 μm (by laser diffractometry) is dispersed in a dispersing medium, and in that the resulting suspension is treated subsequently, using average to high forces, so as to obtain a suspension whereof the solid matter particles have a average particle-size distribution (by photon correlation spectroscopy) less than 3 μm, preferably less than 1 μm (1000 nm), and in particular less than 400 nm, more particularly still, less than 200 nm.
REFERENCES:
patent: 5389382 (1995-02-01), List
patent: 5858410 (1999-01-01), Muller
patent: 6018080 (2000-01-01), Dearn
patent: 6251945 (2001-06-01), Einig
patent: 6551619 (2003-04-01), Penkler et al.
patent: 6565885 (2003-05-01), Tarara
patent: 6607784 (2003-08-01), Kipp
patent: 6696084 (2004-02-01), Pace
patent: 2002/0056206 (2002-05-01), Pace
patent: 2003/0175313 (2003-09-01), Garrec et al.
patent: 2003/0229015 (2003-12-01), Fogelman
patent: 2375992 (2001-01-01), None
patent: 4440337 (1996-05-01), None
patent: 9632095 (1996-10-01), None
patent: 0103670 (2001-01-01), None
patent: 0145677 (2001-06-01), None
patent: 2004060244 (2004-07-01), None
patent: 2004060344 (2004-07-01), None
Rios, “Brining Formulations to Size, Strategies for Micro- and Nanoparticle Development,” Pharmaceutical Technology, Nov. 2004, www.pharmtech.com.
Uekama K. Design and Evaluation of Cyclodextrin-Based Drug Formulation. Chem Pharm Bull, vol. 52, 900-915 (2004) 2004;52(8):900-15.
Merisko-Liversidge E. Nanocrystals: Resolving Pharmaceutical Formulation Issues associated with poorly water-soluble Compounds. In: Marty JJ, editor. Particles; 2002; Orlando: Marcel Dekker; 2002.
Buchmann S, Fischli, W., Thiel, F. P., Alex, R. Aqueous microsuspension, an alternative intravenous formulation for animal studies. In: 42 nd Annual Congress of the International Association for Pharmaceutical Technology (APV); 1996; Mainz; 1996. p. 124.
Mosharraf, M., Nyström, C., The effect of particle size and shape on the surface specific dissolution rate of micronised practically insoluble drugs.Int. J. Pharm., 122, 35-47, 1995.
Rainer H. Muller, Jan Moschwitzer and Faris Nadiem Bushrab, Manufacturing of nanoparticles by milling and homogenization techniques, eds. Gupta, Kompella, Publisher: Marcel Dekker, summitted for printing Jan. 2006; “Nanopartcle Technology for Drug Delivery” Chapter 2 pp. 21-51.
Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future. Advanced Drug Delivery Reviews 2001;47(1):3-19.
Fichera, M.A., Wissing, S.A., Müller, R.H., Effect of 4000 bar homogenisation pressure on particle diminution on drug suspensions, Int. Meeting on Pharm., Biopharm. and Pharm. Technology, Nuremberg, 679-680, 2004.
Sucker, H., Hydrosole—eine Alternative für die parenterale Anwendung von schwer wasserlöslichen Wirkstoffen, in: Müller, R. H., Hildebrand, G. E., (Hrsg.), Pharmazeutische Technologie: Moderne Arznei-formen, 2. Auflage, 1998, WVG, Stuttgart.
Müller R.H., Heinemann, S. Surface Modelling of Microparticles as Parenteral Systems with High Tissue Affinity. In: Gurny, R., Juninger, H. E., ed. Bioadhesion—Possibilities and Future Trends: Wissenschaftliche Verlagsgesellschaft Stuttgart; 1989, 202-214.
Krause, K.P., et al., Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation. Int J Pharm, 2000. 196(2): pp. 169-172.
Abbott & GmbH & Co. KG
Barham Bethany
Manelli Selter PLLC
Melcher Jeffrey S.
Wax Robert A
LandOfFree
Method for producing ultrafine submicronic suspensions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing ultrafine submicronic suspensions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing ultrafine submicronic suspensions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271674